newsfilter
← Latest News
FDA Approved Drugs·

Approval of Ambrisentan, Anda #208441 (Labeling)

Approval Date: 07/25/2025; Drug Name: Ambrisentan, Anda #208441; Active Ingredients: AMBRISENTAN; Company: Mylan; Submission Status: Approval; Submission Classification: Labeling; Application Number: 208441

Company
MYLAN
Keywords
MYLAN